Ian Arnold Shaffer, M.D. Psychiatry & Neurology - Addiction Medicine Medicare: Not Enrolled in Medicare Practice Location: 11303 Walnut Creek Ct, Oakton, VA 22124 Phone: 703-218-3667 Fax: 703-218-3668 |
News Archive
Epilepsy affects 50 million people worldwide, but in a third of these cases, medication cannot keep seizures from occurring. One solution is to shoot a short pulse of electricity to the brain to stamp out the seizure just as it begins to erupt. But brain implants designed to do this have run into a stubborn problem: too many false alarms, triggering unneeded treatment. To solve this, Johns Hopkins biomedical engineers have devised new seizure detection software that, in early testing, significantly cuts the number of unneeded pulses of current that an epilepsy patient would receive.
OPKO Health, Inc. today announced the receipt of a patent allowance from the U.S. Patent and Trademark Office (USPTO) for the patent application titled "Flow Control in Microfluidic Systems".
For the first time, scientists have discovered how C-reactive protein, or CRP, is able to access endothelial cells. The UC Davis researchers' findings will be published in the July issue of Arteriosclerosis, Thrombosis, and Vascular Biology, one of the American Heart Association's leading journals.
ReShape Medical, Inc. today announced that its REDUCE Trial for the ReShape Duo Intragastric Balloon, a non-surgical treatment for weight loss, has met its primary efficacy endpoints.
Has a bone density scan placed you at risk for osteoporosis, leading your doctor to prescribe a widely advertised bone-building medication? Not so fast! A University of Illinois study finds that an effective first course of action is increasing dietary calcium and vitamin D or taking calcium and vitamin D supplements.
› Verified 8 days ago